Faculty Portal

Dr. Rasmita Dash

Ph.D.

Assistant Professor

School of Pharmacy and Life Sciences

Department: NA

Phone: 8895950362

Email: [email protected]

About Me
Rasmita Dash works as an Assistant Professor in the School of Pharmacy and Life Sciences, CUTM, Bhubaneswar. She completed her B.Pharm in 2017, M.pharm Iin 2019 and Ph.D. in 2024 from Siksha ‘O’ Anusandhan (Deemed to be) University. She has published many impactful articles in reputed journals, patents, and book chapters. Her area of interest is conjugated nanoformulation-based drug delivery for treating and managing cancer, atherosclerosis, and inflammation.

About Me

Rasmita Dash works as an Assistant Professor in the School of Pharmacy and Life Sciences, CUTM, Bhubaneswar. She completed her B.Pharm in 2017, M.pharm Iin 2019 and Ph.D. in 2024 from Siksha ‘O’ Anusandhan (Deemed to be) University. She has published many impactful articles in reputed journals, patents, and book chapters. Her area of interest is conjugated nanoformulation-based drug delivery for treating and managing cancer, atherosclerosis, and inflammation.

Research Fields

Nanoformulation based drug delivery

Teaching

4 years

Expertise

Nanoformulation

Interests

Nanoformulation

Sl. No.	Title	Issuer

Publicaion 1

The neglected continuously emerging Marburg virus disease in Africa: A global public health threat.

Publisher: Willey

Volume:

ISBN: 6

Date of Publish: 2023-10-29

Author:

Description:

Publicaion 2

Drug repurposing: A compelling cancer strategy with bottomless opportunities – Clinical updates and a road map for the future

Publisher: Medknow

Volume:

ISBN:

Date of Publish: 2023-11-02

Author:

Description:

Publicaion 3

Modeling of chitosan modified PLGA atorvastatin-curcumin conjugate (AT-CU) nanoparticles, overcoming the barriers associated with PLGA: An approach for better management of atherosclerosis.

Publisher: Elsevier

Volume:

ISBN:

Date of Publish: 2023-06-10

Author:

Description:

Publicaion 4

Novel atorvastatin-curcumin conjugate nanogel, a selective COX2 inhibitor with enhanced biopharmaceutical profile: Design, synthesis, in silco, in vitro, and in vivo investigation

Publisher: Elsevier

Volume:

ISBN:

Date of Publish: 2023-03-01

Author:

Description:

Publicaion 5

An open call for nano-based therapy to address COVID-19 and oncological clinical conditions.

Publisher: Elsevier

Volume:

ISBN:

Date of Publish: 2023-03-27

Author:

Description:

Publicaion 6

Effect of eutectic formulation on Photodegradation kinetics of ornidazole in aqueous state: predicted interaction and molecular binding in docking studies

Publisher: Springer Nature

Volume:

ISBN:

Date of Publish: 2022-01-20

Author:

Description:

Publicaion 7

A contemporary insight into SARS-CoV-2 pathophysiology, retrieved threat of mutants and prospect of vaccine development

Publisher: Edizioni Minerva Medica

Volume:

ISBN:

Date of Publish: 2021-09-21

Author:

Description:

Publicaion 8

Sustained Release Bioadhesive SuppositoryFormulation for Systemic Delivery of Ornidazole: In-silico Docking Study.

Publisher: Indian J of Pharmaceutical Education and Research.

Volume:

ISBN:

Date of Publish: 2019-11-01

Author:

Description:

Faculty Portal | CUTM

Research Fields

Recent Publications (International Journals)

Academic Honors & Awards

The neglected continuously emerging Marburg virus disease in Africa: A global public health threat.

Drug repurposing: A compelling cancer strategy with bottomless opportunities – Clinical updates and a road map for the future

Modeling of chitosan modified PLGA atorvastatin-curcumin conjugate (AT-CU) nanoparticles, overcoming the barriers associated with PLGA: An approach for better management of atherosclerosis.

Novel atorvastatin-curcumin conjugate nanogel, a selective COX2 inhibitor with enhanced biopharmaceutical profile: Design, synthesis, in silco, in vitro, and in vivo investigation

An open call for nano-based therapy to address COVID-19 and oncological clinical conditions.

Effect of eutectic formulation on Photodegradation kinetics of ornidazole in aqueous state: predicted interaction and molecular binding in docking studies

A contemporary insight into SARS-CoV-2 pathophysiology, retrieved threat of mutants and prospect of vaccine development

Sustained Release Bioadhesive SuppositoryFormulation for Systemic Delivery of Ornidazole: In-silico Docking Study.